Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quintara Biosciences provides high-quality DNA sequencing and genomic services to support life science research and drug discovery. The company does not develop its own therapeutics or have clinical programs but enables research through advanced molecular biology services. Founded in California in 2005 by Qun Shan and others, it operates multiple labs across the US—including Cambridge MA headquarters—with an estimated $17.7M revenue as of early 2025. The company does not develop its own therapeutics or diagnostics but serves as an enabling partner for academic researchers and biopharma companies through contract research offerings such as next-generation sequencing, oligo synthesis/gene synthesis/protein expression/purification.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quintara Biosciences.